SCHEMBL16387192

SCHEMBL16387192

CC(C)C1=CCNN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18885187 0.64 CRBN (0.30)
SCHEMBL907942 0.63
SCHEMBL11223089 0.61
Hydrochloric Acid SCHEMBL4412668 0.61
SCHEMBL19723096 0.60
SCHEMBL10205055 0.58
SCHEMBL4630094 0.57
Hydrochloric Acid SCHEMBL4013495 0.56
SCHEMBL9574785 0.56
SCHEMBL11194126 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024138201-A2 SELECTIVE BET INHIBITORS AND USES THEREOF Tay Therapeutics Limited (GB) 2024-06-27 WO disclosed
EP-3877376-B1 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS INC (US) 2023-08-23 EP disclosed
WO-2023275542-A1 PYRROLOPYRIDONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Tay Therapeutics Limited (GB) 2023-01-05 WO disclosed
WO-2020150677-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC. (US) 2020-07-23 WO disclosed
CN-106255688-B Morpholine-pyridine derivate 豪夫迈·罗氏有限公司 2019-11-08 CN disclosed
US-8921378-B2 Androgen receptor modulating carboxamides ORION CORPORATION (FI) 2014-12-30 US disclosed